• The ‘angel’ in the inbox July 26, 2026 Patients think they’re reaching an institution when they message Penn Medicine on social media. What they remember is the person who reached back.
• Traditional food program reduces heart failure hospital visits in Navajo Nation July 26, 2026 A community-designed meal program reduced hospital and emergency visits among heart failure patients in Navajo Nation.
• Different GLP-1 therapies could be tailored to patients’ individual metabolic needs July 26, 2026 A new analysis shows that GLP-1 therapies can deliver distinct benefits to different heart and metabolic health needs beyond just weight loss.
• New therapeutic target expands options for multiple myeloma July 21, 2026 In a Phase I clinical trial, the investigational bispecific antibody cevostamab reduced cancer in more than 40 percent of patients with multiple myeloma.
• Semaglutide sustains lower calorie intake for more than a year July 20, 2026 Penn Medicine researchers find semaglutide impacts remain, even as feelings of hunger gradually return.

Use arrow keys to view news

Use arrow keys to view events